Users' questions

What is the average tibia length?

What is the average tibia length?

The average length of the male tibia on the right was 36.45 cm.; on the left, 36.48 cm. In females the right tibia measured on an average 34.5 cm.; the left, 34.6 cm. The scale of length in the male varies from 31.0 to 45.5 cm., and in the female from 28.0 to 39.0 cm.

How does femur length determine height?

To calculate the estimated height based on the person’s femur, first measure the femur in centimeters. If the subject is female, multiply the length by 2.47 and add 54.1 to arrive at the approximate height. If the subject is male, multiply by 2.32 and add 65.53.

How long is the average fibula?

The average fibula is about 390 millimeters (mm) long in adult men and about 360 mm long in adult women.

How are tibial length measurements used to predict height?

Others have developed height prediction equations based on segmental limb measurements, for example, upper arm length, 12, 15 arm span, forearm length, ulnar segment length, 16, 17 lower leg length, 12 – 14 knee height, 13, 14, 18 – 20 or tibial length, 13, 14 and these have been shown to be reliable for predicting height in children with CP.

What’s the average length of a tibia bone?

Tibia The length represents the distance between the articular surface of the head and tip of the medial malleolus. The length varies from 12″ to 16″, giving anaverage of13-88 whenbothsexes aretakentogether. Inmales, the average length is 14*2′ andin females 13-2′.

How is recumbent length related to tibial length?

In children with CP, correlations between height or recumbent length and knee height, upper arm length and tibial length are similarly high ( r = 0.98, 0.97, and 0.97, respec- tively, p < 0.05) (Stevenson 1995 ) .

What was the purpose of the tibia growth curve?

The purpose of this study was to validate a 3D methodology for measuring tibial lengths (3D tibia length; TL 3D) using anthropometric measurements of tibia length (TL A) and to generate tibia growth curves for ambulatory children and adolescents with CP (GMFCS levels I–III).